TABLE 2.
Summary of antibiotic resistant mechanisms in MRSA.
| Antibiotic class | Resistant mechanism |
|---|---|
| Penicillins and 4 generation of Cephalosporins | Penicillinase, production of PBP2a |
| Carbapenems | Development of PBP2a |
| Tetracyclines | Ribosomal methylation of binding sites, efflux pumps |
| Tigecyclines | Efflux pumps |
| Macrolides and clindamycin | Ribosomal methylation of binding sites, efflux pumps |
| Fluoroquinolones | Mutations in topoisomerase IV and DNA gyrase, efflux pumps |
| Rifampicin | Mutations in RNA polymerase gene |
| TMP/SMX | Mutations in DHPS and DHFR |
| Aminoglycosides | Aminoglycoside degradation enzymes |
| Daptomycin | Electrostatic repulsion through increase to the cell-surface charge |
| Vancomycin | VRSA: altered structure of peptidoglycan precursors from D-Ala-D-Ala to D-Ala-D-Lac; VISA: increased production of peptidoglycan, thicker cell wall, decoy D-Ala-D-Ala dipeptides on cell surface |
| Linezolid | Mutations to the 23S rRNA, altering required modifications to the 23S rRNA, mutations to the 50S ribosomal L3 protein |
Abbreviations: PBP, penicillin binding protein; TMP/SMX, trimethoprim-sulfamethoxazole; DHPS, dihydropteroate synthase; DHFR, dihydrofolate reductase.